AI Science Tracker

Center for Genomic Regulation, Barcelona

1 discovery from 2022

Discoveries

ProtGPT2: a language model generating novel protein sequences

ProtGPT2, a 738-million-parameter autoregressive transformer trained on UniRef50, generates de novo protein sequences in seconds. The authors report the generated sequences are distantly related to natural ones, sample unexplored regions of protein space, and match natural sequences in amino acid and disorder propensities. Caveat: the evaluation is computational (sequence searches and similarity networks), with no experimental validation in the sources checked.

Technology: ProtGPT2 (transformer protein language model)

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: retrospective or benchmark
  • Tested: Generated sequences were assessed computationally: composition and disorder propensities, sequence searches, and AlphaFold-predicted folds; no experiments are described in the abstract read.
  • Still unknown: Not reported in the abstract read; no experimental validation is described.
  • AI role: ProtGPT2, a 738-million-parameter autoregressive transformer trained on UniRef50, generated de novo protein sequences.

Evidence sources: https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=DOI:10.1038/s41467-022-32007-7&resultType=core&format=json

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review scope and date are not recorded; source checked does not establish full-text review.

Citations: in the top 1% of works of the same type, year and subfield (OpenAlex work metrics, 883 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 4/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Open the interactive profile for the timeline, or browse all organizations and model families.